1. Home
  2. LXEO vs PMO Comparison

LXEO vs PMO Comparison

Compare LXEO & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • PMO
  • Stock Information
  • Founded
  • LXEO 2017
  • PMO 1993
  • Country
  • LXEO United States
  • PMO United States
  • Employees
  • LXEO N/A
  • PMO N/A
  • Industry
  • LXEO
  • PMO Finance Companies
  • Sector
  • LXEO
  • PMO Finance
  • Exchange
  • LXEO Nasdaq
  • PMO Nasdaq
  • Market Cap
  • LXEO 314.1M
  • PMO 324.9M
  • IPO Year
  • LXEO 2023
  • PMO N/A
  • Fundamental
  • Price
  • LXEO $6.24
  • PMO $10.43
  • Analyst Decision
  • LXEO Strong Buy
  • PMO
  • Analyst Count
  • LXEO 7
  • PMO 0
  • Target Price
  • LXEO $22.71
  • PMO N/A
  • AVG Volume (30 Days)
  • LXEO 623.4K
  • PMO 99.0K
  • Earning Date
  • LXEO 11-13-2024
  • PMO 01-01-0001
  • Dividend Yield
  • LXEO N/A
  • PMO 4.10%
  • EPS Growth
  • LXEO N/A
  • PMO N/A
  • EPS
  • LXEO N/A
  • PMO 0.42
  • Revenue
  • LXEO N/A
  • PMO N/A
  • Revenue This Year
  • LXEO N/A
  • PMO N/A
  • Revenue Next Year
  • LXEO N/A
  • PMO N/A
  • P/E Ratio
  • LXEO N/A
  • PMO $24.38
  • Revenue Growth
  • LXEO N/A
  • PMO N/A
  • 52 Week Low
  • LXEO $5.77
  • PMO $8.57
  • 52 Week High
  • LXEO $22.33
  • PMO $10.68
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 28.99
  • PMO 46.62
  • Support Level
  • LXEO $5.77
  • PMO $10.30
  • Resistance Level
  • LXEO $11.72
  • PMO $10.54
  • Average True Range (ATR)
  • LXEO 0.85
  • PMO 0.11
  • MACD
  • LXEO -0.19
  • PMO 0.01
  • Stochastic Oscillator
  • LXEO 5.71
  • PMO 53.09

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About PMO Putnam Municipal Opportunities Trust

Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.

Share on Social Networks: